NEWER DRUG DELIVERY
SYSTEMS
Dr.Reshmi.T.R,
Definition
Therapeutic systems that incorporate drugs in
a dosage form that releases the medication
• at a predetermined rate
• over an extended period of time
• from a single application
Demerits of conventional
dosage forms
Large amount of drug delivered
Repeated dosage necessary
Less patient compliance
Fluctuation in drug concentration in blood
Aims of NDDS
• Maintain constant blood levels for longer
period of time
• Decrease frequency of administration
• Improves patient compliance
• Reduce the GI S/E
Types of NDDS
•Prolonged release parenteral preparations
•Local Drug delivery systems
•Targeted delivery systems
•Some more NDDS
PROLONGED RELEASE
PARENTERAL PREPARATIONS
1.Portable pumps
2.Implantable pumps
3.Pens
4.Pellets
5.Dermojet
6..Trandermal delivery system
7.Patient Controlled Analgesia(PCA)
Portable pumps
Insulin Pump
Releases small amount of insulin all day
Steady glucose
Batterypowered device
Parts of the pump
Parts:
Pump
Insulin Reservoir
Computer chip
Infusion set
Insulin flows from pump
Infusion set canula
INSULIN PUMP
Recent Developments
• Pump software
• Alarms
• Interface to computer
• Bluetooth remote
• Touch bolus
Implantable pumps
Intrathecal pump
Deliver drug intrathecal space
Parts:
Metal pump with reservoir to store drug and
catheter to deliver drug
• Surgical procedure
• Catheterspine
PumpSubcutaneou
s
Drug delivered through
catheter to intrathecal
space
Catheter in intrathecal space
• Indications:
• Chronic pain
• Cancer
• Multiple sclerosis
• Chronic pancreatitis
• Drugs:
• Morphine
• Baclofen
Pens
Insulin pens –
Parts: Cartridge , dial, pen needle
Injected S/C with needle
Pellets
Eg: NORPLANT
Contraceptive
6 silicon capsules of 36mg levonorgestrel
Surgical procedure~15mnts
IncisionInsert capsules
subdermally in fanlike shape
Action in 24 hrs
Removal: 2nd
incision
Dermojet
• Needle not used
• High velocity jet of
drug from microfine
orifice
• s/c tissue
• Mass inoculation
Treatment of keloids and hypertrophic scars
with Intralesional dermojet injections of
Bleomycin
Dermojet treatment using Triamcinolone for
alopecia areata
Transdermal drug delivery
system
• Adhesive patches
• drugs delivered at constant rate into systemic
circulation
• Layers:
• Drug in reservoir
• Occlusive backing film
• Rate controlling micropore
• Adhesive with priming dose
• Protective peel off strip
Advantages
Steady plasma conc
Bypass First pass metabolism
Effect lasts for 1-7 days
Convenient
Less side effects
Disadvantages
• Local irritation
Erythema
• Minimised by changing the site of
application
DRUGS:
• Hyoscine - 1st
used
In motion sickness
• GTN , fentanyl , nicotine , clonidine , estradiol
Sites
Chest , abdomen ,upper arm ,lower back,
buttock, mastoid region
Patient Controlled Analgesia
• To administer pain medications
• Patient control dose and amount
• Drugs:
• Morphine
• Bupivacaine
• Indications:Post op pain, cancer pain
Patient Controlled Analgesia
]
Patient Controlled Epidural Analgesia
PCEA
Local Drug delivery systems
1.Ocular drug Delivery systems:
Deliver steady concentration
In ocular tissues
Ocusert
Lacrisert
SODI
Ocusert
• Consists of:
• Central reservoir of Drug enclosed in
microporous membrane
• Ocusert Pilocarpine:
• First in the category
• 2 types:
• Pilo 20 and Pilo 40
• Pilocarpine alginate core
sandwiched in Ethylene vinyl
Acetate membranes
Placed under eyelid
Pilocarpine dissolve In lacrimal fluid
Released through rate controlling membrane
Lasts 7 days
• Side effects
• Miosis
• Myopia
• Drawback:
• Non biodegradable
• Require removal
• Lacrisert
• Erodible insert
• Used in dry eye
syndrome
Rod shaped
Made of hydroxy propyl cellulose
Inserted into inferior fornix
• Inserted into inferior fornix
• Imbibes water from conjunctiva
Form a hydrophilic film which stabilise tear film
Hydrates cornea
Insertion of Lacrisert
SODI
• Soluble Ocular Dug Insert
• First developed for cosmonauts
• Small oval thin film
• Made of Acrylamide Vinyl Pyrolidene Ethylacrylate
• Available for around 20 ophthalmology drugs
• Ex:Ciprofloxacin
Progetasert
• T shaped IUCD
• progesterone at constant rate
65microgram/day * 1 yr
Drug Eluting Stents
Metallic stents covered with drug
Drug gradually released
Prevent restenosis in MI
Eg: Sirolimus,Paclitaxel
Targeted Drug Delivery
Systems
Selective delivery of drugs to specific regions
Improve safety & efficacy
Reduce s/e
Types
Vesicular Drug Delivery
systems
Highly ordered assemblies of lipid bilayer
Can incorporate both hydrophilic and
lipophilic drugs
• Eg:
• Liposomes
• Niosomes
LIPOSOMES
• Concentric shells of Phospholipids in
watery medium
• Vehicle for targeted delivery
Spherical vesicles – 2layers Pospholipid
Cholesterol
Size – nm to several mms
Water soluble drugs- trapped in central
aqueous
compartment.
Lipid soluble drugs- in lipid bilayer
• Examples:
• Anticancer drugs
Doxorubicin
• Antifungal drugs
Amphotericin B
Multilamellar
Vesicles
(MLV)
Several lipid
bilayers
Single
Unilamellar
Vesilces
(SUV)
Single lipid
layer:25nm
Large Unilamellar
vesicles
(LUV)
Single lipid
layer:100nm
CLASSIFICATION OF LIPOSOMES
Mechanism
• Lipid bilayer fuse with cell membrane
• Release contents cytoplasm
Types of Liposomes
Niosomes
• Bilayer of non ionic surface active agents
Liposome
• More expensive
• Less stable
• From phospholipids
• Relatively more toxic
Niosome
• Cheaper
• More stable
• from uncharged
surfactant
• Relatively safer
Other vesicular drug delivery
systems
Genosomes For cell specific gene
transfer
Hemosomes Hb containing liposomes to
carry O2
Photosomes Photolyase incorporated
liposomes for
photodynamic therapy
Ethosomes With polar core for water
soluble drugs
MONOCLONAL ANTIBODIES
• Antibodies produced by a single clone
directed against single antigenic
determinent
• Hybridoma technologylarge scale
production of Mab
• Hybridoma:by fusing B lymphocytes with myeloma cells
• Myeloma cell grown in culture deficient in HGPRTenzyme
• Prevent formation of Ig
• Myeloma cell +B lymphocytesHybridoma
Placed in HAT(Hypoxanthine Aminopterine Thymidine )medium and cloned
Hybridomas survive and replicate
Monoclonal antibodies formed are purified for clinical use
Name of Monoclonal antibody ends with mab
Letter before mabsource
• Letter before the previous
wordsTherapeutic use
• Tutumor
• Vivirus
• Cicirculation
Tu Tumour
Vi Virus
Ci Circulation
Examples
Rituximab Chimeric
Treat tumour-Hodgkins
lymphoma
Palivizumab Humanised
RSV(virus)
NANOMEDICINE
• Nanoparticles used as drug delivery
vehicles
• Size< 100 nm
• Taken up by cells more efficiently
• A nano meter =one billionth of a meter =
250 millionths of an inch.
Different from properties of the bulk material.
Why Nanoparticles?
• Can easily reach tiny capillaries and
secluded areas of body
• High surface to volume ratiodissolution
rate high
• Eg: Nanosuspensions of Paclitaxel and
Cyclosporine has better dissolution rate
• Targeted delivery-depend on particle
size,charge preferentially absorb on
certain organs and tissues
Passive targeting
Spontaneous accumulationin leaky vasculature
Physiology of diseased tissuepH,temperature
Eg: Cancer cells—Pores,bloated gap
junctionsEnhanced permeability and Retention
effect(EPRE)Nanoparticles gather in tumor interstitium
Active targeting
• Moieties like Antibodies/lipids coupled to
drug or delivery systems
• Straps nanodevices to receptor expressed
at target site
Advantages
• Precision administration
• Small dosagesLess side effects
Gold Nanoparticles
Absorb Xrays
Use:Contrast
agenteffective RT
Antibacterial
therapyspecific Ab
selectively kill bacteria
Nanoerythrosomes
• Resealed erythrocytes
used
• Selective for liver and
spleen
• Use:
• Liver disease,Enzyme
disorders
NANOROBOTS
Introduce into body to detect
and repair damages
Use ultrasonic signals
and chemical sensors
• Uses of nanorobots:
• Atherosclerosis:Targeted at plaques
• Cancer:Attack tumors using Ultrasonic
signals
• Deliver medicine directly to diseased
organs
• Diabetes and Hypertension:Nanorobots
with sensors used
Quantum dots
Photodetector device
•Use:
•Chemotherapy illuminating
cancer cells
•Surgeons can see glowing
tumor and remove
Carbon Nanotubules
• Cylindrical shape
• Made of graphite,allotope
of carbon
• Use :
• Cancer
• Gene therapy
• Bronchial Asthma
Miscellaneous NDDS
Sustained release
drugs
Sustained release
drugs ProdrugsProdrugs
Prolonged release oral preparationsProlonged release oral preparations
Sustained release preparation
• Release medication in a predetermined
manner over extended period of time
• Eg:Diclofenac SR
Advantages
• Therapeutic effect for longer duration
• Less frequency of administration
• Less fluctuation
• Lesser side effects
Prodrugs
Inactive compoundBiotransform after
administrationActive compound
Examples of Prodrug :
To increase DOA Esters of Penicillin
To cross BBB  L-dopa in Parkinsonism
For site specific actionMethanamine in UTI
 Advantages :
 More stable
 Better bioavailability
 Less S/E
 Overcome bitter taste
 Improves Bioavailabilty
Newer Prodrugs
Clostridia Directed Enzyme
Prodrug therapy(CDEPT)
• Use Clostridia to convert
prodrug to active form
• Eg:Nitroreductase in
chemotherapy
Antibody directed Enzyme
Prodrug therapy(ADEPT)
• Use antibodies
• Increase tumour
selectivity
• Eg:Azathioprine
Novel Colon Drug Delivery
System
• CODESTM
• Uses Enteric coated Tablet
• Covered with:Lactulosecoated with acid
soluble Enteric coatingcoated with
Enteric coated material
• Outermost layer protects in
stomachdissolves after gastric
emptying
• Second layerprotective in alkaline pH of
Small Intestine
• Colon:Bacterial flora lowers the pH by
reacting with lactulosedrug released
Iontophoresis
• Mild electric current is applied for transport
of drugs across skin
• Eg:vasopressin,dexomethasone
• Dendrimer
• 3D structure(like tree)
• Nanoscale
• Uses:
• Gene delivery
• Anticancer drugs
• Nanoshells
• Can absorb light to
get heated up
• Lethal to cells
• Used in cancer
treatment
Osmotic Drug Delivery
System
• GITS
• Controlled delivery depending on Osmotic
pressure of drug
• Eg:Nifedipine GITS
Inhalable Insulin
• Available in Powdered form
• Delivered with Nebuliser
• Marketed by Pfizer in the name Exubera
• And Mannkind in the name Alfrezza
Newer Drug Delivery Systems
Newer Drug Delivery Systems

Newer Drug Delivery Systems